| 000 | 01367 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512012804.0 | ||
| 264 | 0 | _c19890901 | |
| 008 | 198909s 0 0 eng d | ||
| 022 | _a0020-8167 | ||
| 024 | 7 |
_a10.1097/00004397-198902930-00003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFiore, P M | |
| 245 | 0 | 0 |
_aDrug-induced ocular cicatrization. _h[electronic resource] |
| 260 |
_bInternational ophthalmology clinics _c1989 |
||
| 300 |
_a147-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 |
_aConjunctiva _xpathology |
| 650 | 0 | 4 |
_aConjunctival Diseases _xchemically induced |
| 650 | 0 | 4 |
_aEchothiophate Iodide _xadverse effects |
| 650 | 0 | 4 |
_aEpinephrine _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIdoxuridine _xadverse effects |
| 650 | 0 | 4 | _aImmunosuppression Therapy |
| 650 | 0 | 4 |
_aPemphigoid, Benign Mucous Membrane _xchemically induced |
| 650 | 0 | 4 |
_aPilocarpine _xadverse effects |
| 650 | 0 | 4 |
_aQuaternary Ammonium Compounds _xadverse effects |
| 650 | 0 | 4 |
_aSkin Diseases, Vesiculobullous _xchemically induced |
| 650 | 0 | 4 |
_aTimolol _xadverse effects |
| 650 | 0 | 4 |
_aTretinoin _xtherapeutic use |
| 773 | 0 |
_tInternational ophthalmology clinics _gvol. 29 _gno. 3 _gp. 147-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004397-198902930-00003 _zAvailable from publisher's website |
| 999 |
_c2672211 _d2672211 |
||